Page 17 - Vaccination

Bharat Biotech's Covaxin roll-out for children likely in phases

Vaccine performance, availability being evaluated

US expected to authorise mix-and-match Covid booster shots

Federal regulators are expected to authorize the mixing and matching of COVID-19 booster doses this week in an effort to provide flexibility as the campaign for extra shots expands. The upcoming announcement by the Food and Drug Administration is likely to come along with authorization for boosters of the Moderna and Johnson & Johnson shots and follows the OK for a third dose for the Pfizer vaccine for many Americans last month. The move was previewed Tuesday by a U.S. health official familiar with the matter who was not authorized to speak publicly ahead of the announcement. The FDA was expected to say that using the same brand for a booster was still preferable, especially for the mRNA vaccines from Pfizer and Moderna that have proved most effective against the coronavirus. The agency was still finalizing guidance for the single-shot J&J vaccine. Preliminary results from a government study of different booster combinations found an extra dose of any type revs up levels of ..

Why Covid boosters weren't tweaked to better match variants

And that has some experts wondering if the booster campaign is a bit of a missed opportunity to target delta and its likely descendants

Covid-19 pandemic: Vaccinating children not a priority for now, say experts

They say mRNA vaccines could offer best protection for vulnerable children

U'khand achieves target of 100% first dose Covid vaccination: Dhami

Uttarakhand has administered the first dose of Covid-19 vaccine to its entire eligible population three months ahead of target, Chief Minister Pushkar Singh Dhami said on Sunday

Landmark of 1 bn jabs will be announced at rly stns, on planes: Mandaviya

Announcements will be made on airplanes, ships, metros and at railway stations to mark the moment when India achieves the target of administering 100 cr vaccine doses, Mansukh Mandaviya said

Covid-19: Why some nations have deadlier outbreaks with the same vaccines

A number of countries -- mostly developing economies with less capable healthcare systems -- relied on Chinese or Russian vaccines that have proven less effective than the mRNA shots used in the US

How Gennova is developing India's first indigenous mRNA Covid-19 shot

Where Gennova scores is that it has achieved to crack the stringent sub-zero temperature requirements

Moderna and Johnson & Johnson support Covid-19 vaccine boosters

The FDA panel will meet on Thursday and Friday to weigh the evidence for booster doses

Bharat Biotech's Covaxin gets expert panel's nod for children above 2 years

First Covid-19 vaccine in the world for children this young

Expert panel allows adolescent trials of J&J vaccine with riders

SEC asks J&J to monitor adverse events closely for next three months

Towards policy normalisation

A delay by RBI could increase risks

Covid protection wanes months after second shot, booster needed: Studies

Protective antibodies decreased continuously during the six months after the administration of the second dose of the vaccine, according to a study of about 5,000 Israeli health workers

Covid-19 vaccine needs an injection of pace to keep up with syringe demand

The inoculation programme may suffer from a syringe shortage

Minority-dominated areas score in Covid-19 vaccination in 17 of 27 states

When it came to the first dose, 19 states administered more doses in districts where the Muslim population is higher than average

Sweden, Denmark halt Moderna's Covid-19 vaccine shot for younger people

The Swedish health authority Wednesday cited new data on the increased risk of heart inflammation as a reason for the pause for those aged 30 and under

India logs 18,833 new Covid infections, active cases lowest in 203 days

India added 18,833 new coronavirus infections taking the country's tally of COVID-19 cases to 3,38,71,881, while the active cases declined to 2,46,687, the lowest in 203 days

European Medicines Agency approves Covid booster doses for adults

The Amsterdam-based European Medicines Agency (EMA) has approved booster doses of the Pfizer/BioNTech Covid-19 vaccine for all people aged 18 and over.

Over 881.4 mn Covid-19 doses provided to states/UTs so far: Health ministry

According to the ministry, over 5,28,28,050 crore balance and unutilised COVID-19 vaccine doses are still available with states/UTs to be administered

Argentina to start Covid vaccination of children aged 3-11 by end of 2021

Argentina has confirmed more than 5.25 million COVID-19 cases so far, with over 115,000 fatalities.